The Need for Pediatric Drug Development.
Publication
, Journal Article
Ward, RM; Benjamin, DK; Davis, JM; Gorman, RL; Kauffman, R; Kearns, GL; Murphy, MD; Sherwin, CMT
Published in: J Pediatr
January 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Pediatr
DOI
EISSN
1097-6833
Publication Date
January 2018
Volume
192
Start / End Page
13 / 21
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Thalidomide
- Sulfanilamide
- Pediatrics
- Pediatrics
- Patient Participation
- Humans
- Guidelines as Topic
- Drug Labeling
Citation
APA
Chicago
ICMJE
MLA
NLM
Ward, R. M., Benjamin, D. K., Davis, J. M., Gorman, R. L., Kauffman, R., Kearns, G. L., … Sherwin, C. M. T. (2018). The Need for Pediatric Drug Development. J Pediatr, 192, 13–21. https://doi.org/10.1016/j.jpeds.2017.08.011
Ward, Robert M., Daniel K. Benjamin, Jonathan M. Davis, Richard L. Gorman, Ralph Kauffman, Gregory L. Kearns, Mary Dianne Murphy, and Catherine M. T. Sherwin. “The Need for Pediatric Drug Development.” J Pediatr 192 (January 2018): 13–21. https://doi.org/10.1016/j.jpeds.2017.08.011.
Ward RM, Benjamin DK, Davis JM, Gorman RL, Kauffman R, Kearns GL, et al. The Need for Pediatric Drug Development. J Pediatr. 2018 Jan;192:13–21.
Ward, Robert M., et al. “The Need for Pediatric Drug Development.” J Pediatr, vol. 192, Jan. 2018, pp. 13–21. Pubmed, doi:10.1016/j.jpeds.2017.08.011.
Ward RM, Benjamin DK, Davis JM, Gorman RL, Kauffman R, Kearns GL, Murphy MD, Sherwin CMT. The Need for Pediatric Drug Development. J Pediatr. 2018 Jan;192:13–21.
Published In
J Pediatr
DOI
EISSN
1097-6833
Publication Date
January 2018
Volume
192
Start / End Page
13 / 21
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Thalidomide
- Sulfanilamide
- Pediatrics
- Pediatrics
- Patient Participation
- Humans
- Guidelines as Topic
- Drug Labeling